Rv1129c - p.Gly361Cys


Drug resistance types
6 Sensitive 2 RR-TB 0 HR-TB 11 MDR-TB 6 Pre-XDR-TB 0 XDR-TB 0 Other
lineage Counts
lineage Count
lineage3 2
lineage2.2.1 17
lineage4.4.2 2
lineage2.2.1;lineage4 1
lineage4.6.1.2 1
lineage2.1 2
spoligotype Counts
spoligotype Count
None 25
Geographic prevalence
Country level data for this variant is available for 10 isolates.
Statisctical support
Not enough data to calculate support.
Samples
ID Drug resistance Lineage Country iso2
SRR2100666 Sensitive lineage3 None
SRR1723789 Pre-XDR-TB lineage2.2.1 None
SRR25207107 MDR-TB lineage4.4.2 None
SRR11662640 MDR-TB lineage2.2.1 None
SAMN03246246 RR-TB lineage2.2.1 cn
SRR5709880 MDR-TB lineage2.2.1 th
ERR4810933 MDR-TB lineage2.2.1 cn
SRR1723488 RR-TB lineage2.2.1 None
SRR27069425 Pre-XDR-TB lineage2.2.1 None
SRR1723580 Sensitive lineage2.2.1 cn
SRR11662279 MDR-TB lineage2.2.1 None
ERR4798364 Pre-XDR-TB lineage3 in
SRR21690737 Sensitive lineage2.2.1 None
SRR6824364 Pre-XDR-TB lineage2.2.1;lineage4 cn
SRR21887680 Pre-XDR-TB lineage2.2.1 None
SRR10305971 Pre-XDR-TB lineage2.2.1 None
ERR4810628 MDR-TB lineage4.4.2 cn
SRR12634626 Sensitive lineage4.6.1.2 None
SRR11662414 MDR-TB lineage2.2.1 None
SRR26399630 Sensitive lineage2.1 None
SRR1710108 MDR-TB lineage2.2.1 cn
SRR5074093 Sensitive lineage2.1 vn
SRR1723569 MDR-TB lineage2.2.1 None
SRR6824588 MDR-TB lineage2.2.1 cn
SRR11662671 MDR-TB lineage2.2.1 None